In this study, we demonstrated the crucial role of HSP90A at the crossroads between NANOG signaling and the multi-aggressive properties of immune-edited tumor cells by identifying HSP90AA1 as a NANOG transcriptional target. The gene discussed is NANOG; the disease is neoplasm.